Live Breaking News & Updates on Public Health Sciences At Wake Forest Baptist

Requested Repost 2Nov2011 WINSTON-SALEM, N.C. The poor safety profile of the smoking-cessation drug varenicline (Chantix™) makes it unsuitable for first-line use, according to a study published in the Nov. 2 edition of the journal PLoS One, an online publication of the Public Library of Science. Varenicline, which already carries a "black box warning" from… ....

United States , Winston Salem , North Carolina , United Kingdom , Curtd Furberg , Thomasj Moore , Joseph Glenmullen , Marguerite Beck , Jessica Guenzel , Johnt Maltsberger , University Of East Anglia , Piedmont Triad Research Park , Canadian Medical Association Journalby Furberg , Wake Forest School Of Medicine , Human Services , Institute For Safe Medication Practices , Public Health Sciences At Wake Forest Baptist , Public Library Of Science , Harvard Medical School , Department Of Health , Wake Forest Baptist Health , Wake Forest Baptist Medical Center , Us Veterans Administration , Johns Hopkins University School Of Medicine , Drug Administration , Requested Repost ,